Warfarin: effects of intravenous loading doses and vitamin K on warfarin anticoagulation in the pony
Scott, E.A.; Sandler, G.A.; Byars, T.D.
American Journal of Veterinary Research 39(12): 1888-1891
1978
ISSN/ISBN: 0002-9645 PMID: 749570 Document Number: 126339
Document emailed within 1 workday
Related Documents
Gulløv, A.L.; Koefoed, B.G.; Petersen, P.; Pedersen, T.S.; Andersen, E.D.; Godtfredsen, J.; Boysen, G. 1998: Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study Archives of Internal Medicine 158(14): 1513-1521Wu, W.; Bancroft, J.D.; Suttie, J.W. 1996: Differential effects of warfarin on the intracellular processing of vitamin K-dependent proteins Thrombosis and Haemostasis 76(1): 46-52
Koefoed, B.G.; Feddersen, C.; Gulløv, A.L.; Petersen, P. 1997: Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation Thrombosis and Haemostasis 77(5): 845-848
Guthmann, R.A. 2004: Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin? American Family Physician 70(5): 917-918
Scardi, S. 2000: Warfarin anticoagulation in patients with nonvalvular atrial fibrillation Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 1(5): 708-709
Hamby, L.; Weeks, W.B.; Malikowski, C. 2000: Complications of warfarin therapy: causes, costs, and the role of the anticoagulation clinic Effective Clinical Practice: Ecp 3(4): 179-184
Casner, P.R. 1996: Inability to attain oral anticoagulation: warfarin-rifampin interaction revisited Southern Medical Journal 89(12): 1200-1203
Roberge, R.J.; Rao, P.; Miske, G.R.; Riley, T.J. 2000: Diarrhea-associated over-anticoagulation in a patient taking warfarin: therapeutic role of cholestyramine Veterinary and Human Toxicology 42(6): 351-353
Della Corte, A.; De Feo, M.; Romano, G.; Amarelli, C.; De Santo, L.S.; Nappi, G.; Scardone, M.; Cotrufo, M. 2004: Risk of warfarin anticoagulation in pregnant patients with mechanical heart valve prostheses Journal of Heart Valve Disease 13(Suppl 1): S90
Fihn, S.D.; Callahan, C.M.; Martin, D.C.; McDonell, M.B.; Henikoff, J.G.; White, R.H. 1996: The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics Annals of Internal Medicine 124(11): 970-979
O'Shea, M.; Murphy, A.; Kirby, A.; Allen, G.; O'Shea, S.; Curtin, R. 2016: A Cost Minimisation Analysis of NOACs Compared to Warfarin to Attain Therapeutic Anticoagulation amongst AF Patients, Pre- and Post- Cardioversion Irish Medical Journal 109(10): 480
Sermsathanasawadi, N.; Sritongsathian, C.; Pongrattanaman, N.; Praditsuktavorn, B.; Hongku, K.; Wongwanit, C.; Ruangsetakit, C.; Chinsakchai, K.; Mutirangura, P.; Poungvarin, N. 2015: The Influence of VKORC1 Polymorphisms on Warfarin Doses in Thai Patients with Deep Vein Thrombosis Journal of the Medical Association of Thailand 98(6): 549-554
Vainieri, H.; Wingard, L.B. 1977: Effect of warfarin on the kinetics of the vitamin K-dependent clotting factors in rats Journal of Pharmacology and Experimental Therapeutics 201(2): 507-517
Crowther, M.A.; Ageno, W.; Schnurr, T.; Manfredi, E.; Kinnon, K.; Garcia, D.; Douketis, J.D. 2005: Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin Haematologica 90(1): 137-139
Aomori, T.; Obayashi, K.; Fujita, Y.; Araki, T.; Nakamura, K.; Nakamura, T.; Kurabayashi, M.; Yamamoto, K. 2011: Influence of CYP2C9 and vitamin k oxide reductase complex (VKORC)1 polymorphisms on time to determine the warfarin maintenance dose Die Pharmazie 66(3): 222-225
Amin, T.M.; Sirs, J.A.; Allen, B.V.; Colles, C.M. 1986: Effects of warfarin on blood rheology in navicular disease Research in Veterinary Science 40(3): 308-312
Berkarda, B.; Marrack, P.; Kappler, J.W.; Bakemeier, R.F. 1978: Effects of warfarin administration on the immune response of mice Arzneimittel-Forschung 28(8): 1407-1410
Levy, G.; O'Reilly, R.A.; Wingard, L.B. 1974: Relationship between the kinetics of the anticoagulant effects of racemic warfarin and its individual enantiomers in man Research Communications in Chemical Pathology and Pharmacology 7(2): 359-365
MacCallum, P.K.; Thomson, J.M.; Poller, L. 1990: Effects of fixed minidose warfarin on coagulation and fibrinolysis following major gynaecological surgery Thrombosis and Haemostasis 64(4): 511-515
Chlebowski, R.T.; Gota, C.H.; Chan, K.K.; Weiner, J.M.; Block, J.B.; Bateman, J.R. 1982: Clinical and pharmacokinetic effects of combined warfarin and 5-flourouracil in advanced colon cancer Cancer Research 42(11): 4827-4830